Comprehensive Spectral Flow Cytometry Approach for Concurrent Analysis of Hematopoietic Stem, Progenitor, and Mature Cell Lineages in Murine Bone Marrow - Scorecard - MDSpire

Comprehensive Spectral Flow Cytometry Approach for Concurrent Analysis of Hematopoietic Stem, Progenitor, and Mature Cell Lineages in Murine Bone Marrow

  • By

  • Léa Girondier

  • Manon Richaud

  • Julien MP Grenier

  • Ana Belen Pérez-Oliva

  • Jenny Van Asbeck-van der Wijst

  • Michel Aurrand-Lions

  • Maria De Grandis

  • Christophe Lachaud

  • Cyril Fauriat

  • Laura Braud

  • March 18, 2026

  • 0 min

Share

Clinical Scorecard: Comprehensive Spectral Flow Cytometry Approach for Concurrent Analysis of Hematopoietic Stem, Progenitor, and Mature Cell Lineages in Murine Bone Marrow

At a Glance

CategoryDetail
ConditionHematopoietic disorders including anemia and immunodeficiency
Key MechanismsDisruption of hematopoietic stem cell differentiation
Target PopulationMurine models, specifically aged and β-thalassemic mice
Care SettingResearch laboratories and preclinical studies

Key Highlights

  • Development of a 19-marker spectral flow cytometry panel for comprehensive analysis
  • Simultaneous identification of HSPCs, myeloid, lymphoid, and erythroid populations
  • Validation in aged and β-thalassemic mouse models demonstrating sensitivity to hematopoietic alterations
  • Single-tube approach consolidates multiple conventional panels, reducing sample consumption
  • Supports evaluation of emerging therapies targeting hematopoietic progenitor cells

Guideline-Based Recommendations

Diagnosis

  • Utilize the 19-marker panel for accurate identification of hematopoietic populations

Management

  • Employ the panel for monitoring treatment effects in preclinical models of hematopoietic disorders

Monitoring & Follow-up

  • Assess hematopoietic trajectories and progenitor targeting using reporter-based readouts

Risks

  • Consider potential variability in biological samples when interpreting results

Patient & Prescribing Data

Not applicable; study focused on murine models

Panel designed to evaluate gene therapy and RNA-based approaches for hematopoietic conditions

Clinical Best Practices

  • Implement high-dimensional flow cytometry for comprehensive hematopoietic analysis
  • Use UMAP visualization for understanding differentiation trajectories
  • Validate findings in relevant mouse models to ensure translational applicability

References

Original Source(s)

Comprehensive Spectral Flow Cytometry Approach for Concurrent Analysis of Hematopoietic Stem, Progenitor, and Mature Cell Lineages in Murine Bone Marrow

  • by Léa Girondier, Manon Richaud, Julien MP Grenier, Ana Belen Pérez-Oliva, Jenny Van Asbeck-van der Wijst, Michel Aurrand-Lions, Maria De Grandis, Christophe Lachaud, Cyril Fauriat, Laura Braud

  • March 18, 2026

Related Content

The Role of Hemoglobin and Anemia in Preventing Dementia—Revisiting a Well-Known Protein

Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

Health-economic evaluation of a novel personalized digital avatar-based anemia management software in hemodialysis patients